COLLEGE PARK, Md.--(BUSINESS WIRE)--Immuta, the leading provider of enterprise data management solutions for artificial intelligence (AI), today announced a new customer relationship with Cognoa, which provides an AI-based solution for pediatric behavioral health diagnostics and digital therapies. Cognoa utilizes Immuta’s platform to ensure data access policies are consistently and accurately enforced across a wide variety of data sources and users driving their machine learning programs.

Palo Alto, CA-based Cognoa trains algorithms to aid in the diagnosis of behavioral health conditions, including autism and ADHD, with highly sensitive data from a production database which lives in a HIPAA environment. Data privacy and security concerns are paramount for the company, and Cognoa needed a platform that would enforce data access roles, permissions, and policies beyond the standard resource or table-based control levels.

Halim Abbas, Chief AI Officer, Cognoa

“We have a group of very talented data scientists who build our run-time engine for diagnostics software. Our legacy practice of providing them with all of the data they required to build models, while removing the ePHI and HIPAA sensitive information, was extremely time and labor intensive. It was essential to expedite this process, and to also continue to anonymize sensitive information for reporting.”

To meet Cognoa’s needs, Immuta applied purpose-based restrictions to data available natively through its platform, dynamically enforcing data access and policy restrictions based on the data scientist’s needs in real-time. Immuta also applied masking techniques to create a view of Cognoa’s data where sensitive information was included, and any identifiers, such as names and birthdates, were anonymized.

Abbas continued, “With Immuta in place, we have been able to streamline both data science and engineering teamwork, dynamically adapt in real time, and accelerate overall productivity. All the while, we’re also able to define and enforce detailed data access policies that guarantee the security and anonymity of sensitive data to meet or surpass industry regulations.”

Matt Carroll, Chief Executive Officer, Immuta

“Cognoa is on the cutting edge of AI-based medical diagnostics with the important goal of empowering physicians and families to identify behavioral health conditions early when treatments have the greatest potential for improved lifelong outcomes. Immuta’s mission is to ensure the legal and ethical use of data through self-service access and control of highly sensitive information used in the development of machine learning and AI. We’re proud to partner with Cognoa and support its delivery of HIPAA-compliant algorithms within a stringent regulatory environment.”

Read the complete Cognoa case study https://www.immuta.com/cognoa-healthcare-ai-case-study/.

Additional Resources

• For more information on Immuta’s platform, please visit www.immuta.com.
• Click here to request an Immuta demo.
• Follow our blog, and join the conversation on Twitter, LinkedIn, and Vimeo.

About Cognoa

Cognoa is developing AI-based digital diagnostics and personalized therapies that are designed to make earlier diagnoses and effective treatments available to more children to improve outcomes and lower behavioral healthcare costs. When more physicians are empowered to identify and begin treating behavioral conditions and developmental delays earlier, more children have the opportunity to benefit from treatments at a younger age when there is the greatest potential for improved lifelong outcomes. Cognoa currently provides the Cognoa Child Development app via partnerships with employers, payees, and ABA therapy centers to empower parents and caregivers to better support their children’s unique behavioral health and growth. Cognoa is working on the development of a Diagnostic Device intended to aid healthcare providers to deliver a diagnosis of Autism Spectrum Disorder for children at risk for developmental delays. Cognoa intends to seek FDA review and clearance that will allow the company to support diagnostic claims with robust clinical data. For more information, visit https://www.cognoa.com.

About Immuta

Immuta is the fastest way for algorithm-driven enterprises to accelerate the development and control of machine learning and advanced analytics. The company’s hyperscale data management platform provides data scientists with rapid, personalized data access to dramatically improve the creation, deployment and auditability of machine learning and AI. Founded in 2014, Immuta is headquartered in College Park, Maryland.